Drug firm Indoco Remedies on Monday said its Goa-based manufacturing facility has received the EU good manufacturing
practice (GMP) certification from the UK health regulator.
This is an outcome of the last successful inspection conducted by UK Medicines and Healthcare Products Regulatory
Agency (MHRA) from September 16-20 this year, the company said in a regulatory filing.
"The receipt of EU GMP certification from MHRA for our sterile manufacturing unit is encouraging and
reflects immense learning and adaptation of a compliant culture by our technical team," Indoco Remedies Managing Director Aditi
Kare Panandikar said.
Shares of Indoco Remedies were trading 4.31 percent up at Rs 154.90 apiece on the BSE.
|